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Mini-abstract 
 
Large cartilage grafts were engineered in vitro using human nasal chondrocytes loaded into non-
woven meshes, implanted in nude mice and assessed histologically, biochemically and 
biomechanically. We demonstrated the importance of graft pre-cultivation to enhance the clinically 
relevant biomechanical characteristics (i.e., suture retention at implantation and tensile/bending 
stiffness 2 weeks post-implantation).  
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Structured abstract 
Objective: To investigate if pre-cultivation of human engineered nasal cartilage grafts of clinically 
relevant size would increase the suture retention strength at implantation and the tensile and bending 
stiffness 2 weeks after implantation. 
Summary Background Information: In order to be used for reconstruction of nasal cartilage defects, 
engineered grafts need to be reliably sutured at implantation and resist to bending/tension forces 
about 2 weeks after surgery, when fixation is typically removed.  
Methods: Nasal septum chondrocytes from 4 donors were expanded for 2 passages and statically 
loaded on 15x5x2mm size non-woven meshes of esterified hyaluronan (Hyaff®-11). Constructs were 
implanted for 2 weeks in nude mice between muscle fascia and subcutaneous tissue either directly 
after cell seeding, or after 2 or 4 weeks pre-culture in chondrogenic medium. Engineered tissues and 
native nasal cartilage were assessed histologically, biochemically and biomechanically.  
Results: Engineered constructs reproducibly developed with culture time into cartilaginous tissues 
with increasing content of glycosaminoglycans and collagen type II. Suture retention strength was 
significantly higher (3.6±2.2 fold) in 2-week pre-cultured constructs than in freshly seeded meshes. 
Following in vivo implantation, tissues further developed and maintained the original scaffold size and 
shape. The bending stiffness was significantly higher (1.8±0.8 fold) if constructs were pre-cultured for 
2 weeks than if they were directly implanted, whereas tensile stiffness was close to native cartilage in 
all groups.  
Conclusion: In our experimental set-up, pre-culture for 2 weeks was necessary to engineered nasal 
cartilage grafts with enhanced mechanical properties relevant for clinical use in facial reconstructive 
surgery.  
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Introduction 
Autologous cartilage grafts are frequently utilized in reconstructive and aesthetic surgery of the nose. 
The main disadvantages of this approach are the limited availability of tissue, morbidity at the donor 
site1,2 and time consuming surgery. In fact, the external ear and nasal septum provide only limited 
quantities of cartilage, and harvesting larger amounts of costal cartilage may lead to acute or delayed 
complications such as pneumothorax or chest wall deformities 3. Tissue engineering offers the 
possibility of producing large quantities of cartilage of autologous origin, starting from a small tissue 
biopsy and thus with minimal donor site morbidity. Recent studies have shown that human nasal 
chondrocytes released form a tissue biopsy and de-differentiated by expansion in monolayers, have 
the capacity to re-differentiate and generate cartilaginous tissue structures when cultured at high 
density (e.g., in micromasses or pellets 4,5) or in a variety of porous scaffolds6,7.  
In order to be used in a clinical setting for nasal reconstructive surgery, engineered cartilage grafts 
need to have sufficient mechanical integrity (i.e., suture retention strength) at the time of implantation, 
to allow for reliable suturing at the recipient site, and sufficient mechanical stability (i.e., tensile and 
bending stiffness) when fixation is typically removed (i.e., 2 weeks after implantation), to resist 
contraction by scar tissue formation and by exposure to local or external forces in the recipient bed. 
So far, however, both native cartilage tissue and engineered cartilage grafts have been mostly 
characterized biomechanically in terms of compressive stiffness 7-9, which would be of limited 
relevance for nasal reconstruction.  
Another important issue to be addressed towards the clinical use of engineered cartilage grafts is the 
extent of pre-cultivation of cell-scaffold constructs prior to their implantation. In this context, previous 
studies indicated that pre-cultivated engineered cartilage tissues not only reach a superior quality, but 
display a higher capacity to further develop upon implantation than scaffolds implanted directly after 
seeding 10,11, possibly due to less fibrous tissue and blood vessel ingrowth. However, an independent 
study reported that in vitro culture time had only a minor influence on construct development 7: the 
issue is thus still controversial and is likely related to the scaffold used and the specific pre-cultivation 
conditions. 
Based on the above design considerations, the aim of this study was to investigate if pre-cultivation of 
human tissue engineered nasal cartilage grafts of clinically relevant size would increase the suture 
retention strength before implantation and the tensile and bending stiffness at 2 weeks post-
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implantation. In order to address this question, the selected model system consisted of human nasal 
chondrocytes, de- and re-differentiated using previously identified culture medium supplements 4,10,  
and loaded into non-woven meshes made of esterified hyaluronic acid (Hyaff®-11, Fidia Advanced 
Biopolymers, Abano Terme, IT), already in clinical use for the repair of articular cartilage12. The in vivo 
model consisted of ectopic implantation in nude mice, in a pocket between excised muscle fascia and 
subcutaneous tissue, resembling the environment where nasal cartilage grafts would be clinically 
implanted (i.e., highly vascularized mucosal tissue on one side, and thin layer of subcutaneous tissue 
on the other side). 
 
Materials and Methods 
Cartilage biopsies 
Human nasal septal cartilage biopsies from 4 patients  (mean age 48.8, range 34-61 years) were 
harvested at the Institute of Pathology and Forensic Medicine in Basel, following protocol approval by 
the local ethical committee (Ref.-No.: EK 40/03 and EK 263/03). Tissue harvesting was performed 
prior to the autopsy (within 36 hours post-mortem) under sterile conditions, with meticulous care to 
minimize mechanical trauma to the specimens. The incisions were made according to standard 
principles of plastic surgery in order to avoid disfigurement. A sample of about 1.5 x 2 cm of cartilage 
was removed by an interseptocolumellar approach and careful separation from mucosa and 
perichondrium. The specimen was divided into two pieces: one part for cell isolation and tissue 
engineering, and the other for histological, biochemical and biomechanical characterization, as 
detailed below. 
 
Chondrocyte isolation and expansion 
Chondrocytes were isolated by 22-hour incubation at 37°C in 0.15% type II collagenase and 
resuspended in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum, 4.5 
mg/mL D-glucose, 0.1mM nonessential amino acids, 1 mM sodium pyruvate, 100 mM HEPES buffer, 
100 U/mL penicillin, 100 µg/mL streptomycin and 0.29 mg/mL L-glutamine (complete medium). 
Chondrocytes were plated in plastic dishes at a density of 104 cells/cm2 in complete medium further 
supplemented with  1 ng/mL Transforming growth factor-β1 (TGF-β1), 5 ng/mL Fibroblast growth 
factor-2 (FGF-2) and 10 ng/mL Platelet-derived growth factor-bb (PDGF-bb) (all from R&D Systems, 
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Minneapolis, MN). This specific combination of growth factors was previously shown to enhance 
human nasal chondrocyte proliferation and post expansion differentiation ability 4. When sub-
confluent, cells were detached by sequential treatment with 0.3% type II collagenase and 0.05% 
trypsin/0.53 mM EDTA, and replated at 5 x 103 cells/cm2. Before reaching again confluence, cells 
were detached and seeded on scaffolds as described below. 
 
Chondrocyte seeding and culture on three-dimensional scaffolds 
Cells were statically seeded at a density of 6.7E+07 cells/cm3 on non-woven meshes (15mm width x 
5mm length x 2mm thickness fleeces) made of esterified hyaluronic acid (Hyaff®-11, Fidia Advanced 
Biopolymers, Abano Terme, IT). Scaffolds were placed on dishes coated with a thin film of 1% 
agarose to prevent cell attachment to the dish bottom, and a cell suspension (1E+07cells in 60 µl) 
was distributed on the top surface. Constructs were statically cultured for 2 or 4 weeks in complete 
medium supplemented with 10 µg/mL insulin, 0.1 mM ascorbic acid and 10 ng/mL TGF-β3, with 
culture medium completely replaced twice a week. These supplements were previously shown to 
enhance chondrogenesis of de-differentiated human chondrocytes during culture into Hyaff-11 non-
woven meshes 10. Constructs (N = 3 per condition for each donor), immediately after cell seeding or 
following pre-culture, were either processed for histological, biochemical and biomechanical 
characterization or implanted in nude mice, as described below.  
 
Construct implantation 
Freshly seeded scaffolds, constructs pre-cultured for 2 weeks, for 4 weeks and cell-free scaffolds as 
control were implanted in the back of nude mice (CD-1 nu/nu, athymic, 6 to 8-week-old females) in a 
pocket between excised muscle fascia and subcutaneous tissue. All animals in this study were cared 
for and treated according to institutional guidelines. Each mouse received two grafts, and grafts from 
the same experimental group were implanted in different mice. Constructs were harvested after 2 
weeks, corresponding - in the clinical setting – to the time when fixation is typically removed and thus 
when the constructs shall have reached adequate biomechanical properties.  
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Histological analysis 
Tissue constructs were fixed in 4% formalin for 24 h at 4°C, dehydrated, embedded in paraffin, and 




Native cartilage samples and tissue constructs were weighed and digested with proteinase K (1 
mg/ml protease K in 50 mM Tris with 1 mM EDTA, 1 mM iodoacetamide, and 10 µg/mL pepstatin-A) 
for 15 h at 56°C 13. GAG contents were measured spectrophotometrically using dimethylmethylene 
blue dye 14, with chondroitin sulfate as a standard. The GAG content was expressed as percentage of 
tissue wet weight. Total collagen and type II collagen contents were determined respectively by 
measurement of hydroxyproline and by inhibition enzyme-linked immunosorbent assay (ELISA), as 
previously described 15.  
 
Biomechanical testing  
Specimens were maintained in phosphate buffered solution prior to all mechanical tests and kept 
moist during the tests. The width and thickness of the specimens were measured with a Vernier 
caliper. All tests were performed by applying deflections and measuring the corresponding forces 
using a standard miniature mechanical testing instrument (MTS Synergie 100, MTS Systems 
Corporation, Eden Prairie, MN, USA), with data transmitted to a standard personal computer for 
subsequent calculations. Tests were conducted at room temperature. 
Three point bending test 
This test produces data showing the relationship between force and deflection (bending) of the 
specimen in the direction of the force, from which it is possible to obtain the bending stiffness of the 
material, a key property for materials required to maintain the shape of a structure such as the nasal 
septum. Generally, point loading occurs only if specimens have a cylindrical cross-section, whereas 
for rectangular cross-section specimens, like those used in these studies, line loading is performed 
(Fig. 1A). The approximate bending stiffness or modulus EB of the specimen at the deflection rate of 
20 mm/minute was calculated based on the assumption that the specimen is homogenous, using the 
formula: 
 









where F is the applied force, fm is the bending deflection in the direction of the force, and I is the 
second moment of area, which measures the efficiency of a specific shape in resisting bending in the 
direction of loading. For a rectangular section of width b and height d, the second moment of area is: 
(2) 
12
3bdI =  
For this study the support span was 10.2 mm and 1 mm was chosen as the maximal deflection. Only 
data from deflections in the range between 0.4 mm and 0.9 mm, where the measured forces 
increased almost linearly with increasing displacement, were used to calculate the slope of the 
load/deflection regression line. Each specimen was deflected 11 times, turned over and deflected 11 
times again. Data from the first bending cycle and those during unloading were excluded. For each 
specimen, the bending stiffness was calculated as the mean of average values obtained in both 
orientations (before and after turn-over).  
Tensile test 
This test determines the elastic modulus in tension, ET , of the specimen as the ratio of tensile stress 
to strain in the elastic region, as follows: 
(3) ET = (F/A) / (∆l/lO) 
where A is the specimen cross-sectional area at the original length lO and ∆l is the change in length 
between the zero force and the maximum recorded force, F. The specimens were secured at their 
lower end with a suture of a type that would be used clinically to secure a construct to the surrounding 
tissue (POLYSORBTM 5-0, coated, braided lactomer 9-1, synthetic absorbable suture with a P-13 
needle, SynetureTM). The suture was inserted 1 to 2 mm above the lower end of the specimen 
(Fig.1B) and fixed with a flying triple knot to the holding hook affixed to the base plate of the 
mechanical test machine. The knot from the suture was additionally held by a needle holder to reduce 
the internal sliding from the knot. The upper end of the specimen was gripped with an Allis tissue 
forceps (15 cm, 4 x 5 teeth), hung from a rigid metal hook attached to the load cell of the test 
instrument. On each specimen different points were marked with a pen to identify a fixed initial 
specimen "gauge" length, whose changes were analysed from video-sequences recorded during the 
force/elongation tests. The gauge length was between 5 and 10 mm in all cases. The video images 
were calibrated by recording a plastic scale placed at the same distance relative to the camera as the 
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sample. Each specimen was first elongated 3 times to create a maximum length change of 1.2 mm, 
returning the actuator to the original position after each elongation. Subsequent additional sets of 3 
elongations were performed with maximal length changes of 1.8, 2.4 and 3 mm, unless the resultant 
force produced specimen failure (i.e., the suture tearing the tissue). The rate of elongation was set at 
24 mm/minute. The calculated value of ET is approximate for several reasons, including (i) the 
assumption that the specimen is homogeneous in composition and structure, (ii) the use of an 
arbitrary rate of strain, (iii) the use of the initial rather than instantaneous area of the cross-section in 
the computation, and (iv) the assumption of linear force/displacement behavior over the data range 
used in the computations. Thus, the test was not performed to obtain precise material property data, 
but rather to derive relative comparisons on the tensile performance of specimens in a test resembling 
some aspects of in vivo loading. 
Suture pull out test 
The suture pull out test was performed to measure the maximal force that could be applied on a 
suture in the axial direction before pulling out from the construct. The setup was the same as in the 
tension test described above: at the end of the tension test, the actuator was programmed to continue 
elongation at a rate of 24 mm/minute until the suture pulled out of the specimen. The maximal applied 
force was normalized to the specimen thickness, measured prior to performing the tests, and is 
reported as N/mm. 
 
Statistical analysis 
Data are presented as mean ± standard deviation of results obtained from at least 3 constructs 
generated for each of the 4 donors. Mean values were compared using Mann-Whitney tests. 
Statistical analyses were performed using the Sigma Stat software (SPSS Inc., Version 13), with 
p<0.05 as the criteria for statistical significance. 
 
Results 
Engineered tissues following in vitro culture 
Nasal chondrocytes from all donors could be reproducibly expanded in monolayers and underwent an 
average of 9.6 doublings in 14 days. After cell loading into the scaffolds, the resulting constructs 
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maintained the original size and shape, and already after 2 weeks of culture acquired a typical 
cartilaginous glossy appearance, with a firmer consistency than the original fleece (Fig. 2).  
Histological cross-sections of the generated constructs indicated progressive temporal development 
of cartilaginous tissues (Fig. 3A-C). Freshly seeded scaffolds consisted only of a network of 
fibroblastic cells among Hyaff®-11 fibers (Fig. 3A). Extracellular matrix was abundant after 2 and 4 
weeks of culture, with an increasing intensity of Safranin-O staining for GAG with time (Fig. 3B, C). 
Cells in pre-cultured constructs appeared chondrocytic, with a round morphology and embedded in 
large lacunae. 
 Biochemical analysis (Fig. 4A-C) of the pre-cultured constructs was consistent with their 
histological appearance. Wet weight fractions of GAG, total collagen and type II collagen were 
negligible in freshly seeded scaffolds and significantly increased following pre-culture, reaching levels 
respectively 5.5-, 8.1- and 19.5-fold lower than in the native cartilage specimens (respectively 3.3 ± 
1.4, 7.8 ± 2.1 and 7.4 ± 2.0).  
The suture pull out force normalized to the specimen's thickness (Fig. 4D) was 3.6-fold higher 
in 2 week pre-cultured constructs than in freshly seeded scaffolds, did not further increase with longer 
pre-culture time and reached levels 4.3-fold lower than those measured in native nasal cartilage (4.5  
± 1.9 N/mm). The suture pull out strength of the cell-free scaffolds was below the sensitivity of the 
test. 
 
Engineered tissues following in vivo implantation 
After 2 weeks’ implantation, all constructs maintained the original size and shape of the graft and 
displayed a smooth, shiny surface. Tissues generated by freshly seeded scaffolds were weakly 
stained for Safranin-O (Fig 3D). Constructs pre-cultured for 2 or 4 weeks yielded tissues with stronger 
staining intensity for GAG, but predominantly in the inner region (Fig. 3E, F), where cells had a more 
chondrocytic morphology and were at lower density. No vascularization or mineralization was 
observed in any of the explants. Constructs derived by implantation of cell-free scaffolds had a very 
soft consistency and displayed histologically a large amount of vascular ingrowth, without any sign of 
cartilaginous matrix (data not shown). 
 The wet weight fractions of GAG and total collagen (Fig. 5A, B) were similar in explants that 
were grafted immediately after cell seeding or following 2 weeks of pre-culture, and significantly 
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higher if grafts were pre-cultured for 4 weeks, reaching levels respectively 4.5- and 4.0-fold lower than 
in native nasal cartilage. The wet weight fractions of collagen type II following in vivo implantation 
(Fig. 5C) were significantly higher if constructs were pre-cultured for 2 or 4 weeks prior to implantation 
than if constructs were implanted directly after seeding, and reached levels 13.1-fold lower than in 
native cartilage. 
The modulus of elasticity in tension following 2 weeks of in vivo implantation (Fig. 5D) was not 
significantly different if constructs were grafted immediately after cell seeding or following 2 or 4 
weeks of pre-culture. The level reached was 2.7-fold lower than in native nasal cartilage (6.4 ± 
2.4N/mm2). Instead, the modulus of elasticity in bending following 2 weeks of in vivo implantation was 
significantly higher (rsp. 1.8/2.3 - fold) if constructs were grafted after 2 or 4 weeks of pre-culture than 
immediately after cell seeding (Fig. 5E). The level reached was 7.4-fold lower than in native nasal 
cartilage (6.8 ± 3.8N/mm2). The mechanical properties of the implanted cell-free scaffolds were below 
the detection level of the biomechanical test setup. 
 
Discussion 
With the ultimate goal of the clinical use of engineered cartilage for nasal reconstruction, in 
this study we demonstrated that pre-cultivation of human nasal chondrocytes into Hyaff®-11 non-
woven meshes for 2 weeks yields engineered grafts with (i) significantly higher suture retention 
strength, a pre-requisite for reliable implantation, and (ii) significantly higher bending stiffness after 2 
weeks’ implantation, a pre-requisite for safe removal of external fixation. Moreover, pre-cultivated 
engineered tissues were reproducibly approaching histological and biochemical properties of native 
nasal cartilage, which would be required to prevent fibrous tissue and vascular ingrowth and thus to 
support long-term stability of the graft. 
Human nasal chondrocytes have been previously reported to have the capacity to generate 
hyaline-like cartilaginous tissues after monolayer expansion, to a higher extent than articular 16 and rib 
4 chondrocytes. In addition, unlike articular chondrocytes 17, the age of the donor and quality of the 
donor tissue did not effect the cell chondrogenic capacity following monolayer expansion 7, indicating 
that tissue engineering of human septal cartilage is likely possible over a wide age range 7. Our 
results further emphasize the reproducibility of engineering cartilage tissues starting from human 
nasal chondrocytes.  
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Despite previous extensive characterization of human engineered nasal cartilage, to the best 
of our knowledge the present study is the first to use an experimental design based on clinically 
relevant parameters and related to issues which need to be addressed towards a clinical 
implementation of the procedure. In particular, the size and shape of the graft (i.e., 1.5 x 0.5 cm 
beam) would be compatible with the use in a variety of reconstructive surgeries of the nose, including 
treatment of defects at the nasal septum or alar. The extent of cell expansion (i.e., about 10 
doublings), considering a previously determined yield of about 3.5E3 cells/mg of nasal cartilage tissue 
4, would be in the range of that required to have a sufficient number of cells starting from a biopsy of a 
few milligrams. Unlike subcutaneous implantation used by previous studies 7,9, the in vivo model was 
selected to more closely resemble the environment of nasal cartilage, namely a pocket between 
muscle fascia and subcutaneous tissue, and in vivo implantation was for a shorter period (2 weeks), 
which is clinically critical as the typical time before external fixation is removed. Most importantly, the 
biomechanical properties assessed were those specifically required for a graft to resist contraction by 
scar tissue formation and by exposure to local or external forces in the recipient bed, as opposed to 
previously characterized properties in compression or indentation tests 7,9.  
 Rotter et al. observed only minor differences in the in vivo formation of engineered nasal 
cartilage when PLA/PGA scaffolds were implanted immediately after seeding or following pre-culture 
for 3 weeks 7. The discrepancy in comparison to our results could be explained by a number of 
different factors including the scaffold used, specific growth factors inducing chondrocyte 
redifferentiation, the time point of explantation and the different mechanical properties assessed. In 
this regard, however, it should be pointed out that the experimental design of our study did not include 
different times of implantation, and thus does not allow to derive a conclusion on whether in vitro pre-
culture effectively enhances cartilage tissue development in vivo or simply anticipates the time to 
reach a defined level of quality.  
The scaffold used for this study is a non-woven mesh composed of a benzylic ester of 
hyaluronic acid, a molecule naturally present in all soft tissues and playing an essential role in the 
maintenance of the normal extracellular matrix structure 18. The resulting material, commercially 
known as Hyaff®-11 and available in different forms (e.g., sponges, meshes), has been extensively 
used for studies on cartilage tissue engineering10,18-20 and is already in clinical use for the repair of 
articular cartilage defects 12. The result that a pre-culture of 2 weeks improved the suture retention 
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strength of engineered grafts is clearly related to the fact that the mesh used has intrinsically 
negligible mechanical properties. This observation allows to conclude that the mechanical properties 
reached by the grafts were merely due to the deposition and/or functional organization of new 
extracellular matrix, and therefore are not likely to reduce with time due to scaffold degradation. 
Interestingly, the modulus of elasticity in tension was not modulated by pre-cultivation time, and 
reached levels closest to native tissue as compared to all other parameters, suggesting that tensile 
properties of engineered cartilage are not a critical read-out in quality assessment. A longer 
implantation time was not the objective of the present study, although previous works 7,9 reported that 
engineered nasal cartilage tissues improved biochemical and biomechanical similarity to native tissue 
with time of implantation. The lack of a direct correlation between the collagen and GAG content and 
the measured mechanical properties of the tissues suggests the importance of a functional 
organization of those molecules and prompts for future investigations on the assessment of the level 
of collagen crosslinking.   
In conclusion, the results of the present study demonstrate the possibility to develop in vitro a 
nasal cartilage graft with clinically relevant size and biomechanical properties. Furthermore, our data 
indicate a possible advantage in the pre-culturing of engineered human nasal cartilage grafts for 2 
weeks prior to implantation, and together with other promising reports on the topic prompt for the 
clinical test of pre-cultivated grafts in nasal reconstructive surgery. 
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Figure legends 
 
Figure 1: Biomechanical setup 
Schematic diagrams and macroscopic views of setup configurations for the three point bending test 
(A) and the suture pull out test (B) 
 
Figure 2. Macroscopical appearance of engineered cartilage 
Glossy appearance and firm consistency of a typical engineered nasal cartilage graft after 2 weeks of 
pre-culture, prior to implantation. 
 
Figure 3. Histological appearance of the grafts  
Representative Safranin O-stained cross sections of constructs generated by nasal chondrocytes 
freshly seeded (A,C), pre-cultured for 2 weeks (B,D) or pre-cultured for 4 weeks (C,E) into Hyaff®-11 
meshes, before (A,B,C) or after (D,E,F) 2 additional weeks of implantation in nude mice. Arrows (see 
B) indicate undegraded polymer fibers. Scale bar = 100 µm (left panels) or 40  µm (right panels).  
 
Figure 4. Properties of engineered nasal cartilage grafts after in vitro preculture. 
Wet weight fractions of GAG (A), total collagen (B), collagen type II (C) and suture pull out force, 
normalized to specimen thickness (D) in constructs generated by nasal chondrocytes, freshly seeded 
or pre-cultured for 2 or 4 weeks into Hyaff®-11 meshes. * = statistically significant difference from the 
freshly seeded group; °  = statistically significant difference from the 2 weeks pre-culture group. 
 
Figure 5. Properties of engineered nasal cartilage grafts after 2 weeks of in vivo implantation.  
Wet weight fractions of GAG (A), total collagen (B), collagen type II (C), and modulus of elasticity in 
tension (D) or in bending (E) in grafts explanted after 2 weeks of implantation in nude mice. 
Constructs were generated by nasal chondrocytes, freshly seeded or pre-cultured for 2 or 4 weeks 
into Hyaff®-11 meshes prior to implantation. * = statistically significant difference from the freshly 
seeded group; °  = statistically significant difference from the 2 weeks pre-culture group. 
 
 
 
